Impact of expression of the uPA system in sarcomas

Keyphrases

• Plasminogen Activator inhibitor-1 (PAI-1) 100%
• Sarcoma 100%
• Underlining 50%
• Clinical Data 50%
• Breast Cancer 50%
• Clinical Impact 50%
• Tumor Subtype 50%
• Published Data 50%
• Urokinase-type Plasminogen Activator 50%
• Prognostic Impact 50%
• Survival Data 50%
• Cell Surface Receptor 50%
• Tumor Biomarkers 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Receptor 100%
• Connective Tissue Cancer 100%
• Breast Cancer 50%
• Cell Surface Receptor 50%
• Neoplasm 50%
• Tumor Marker 50%
• Urokinase 50%